Medroxyprogesterone acetate capsules

Animal experiments show that this product has a certain inhibitory effect on transplanted tumors, such as breast cancer tumors. Its anti-tumor effect is related to its progesterone activity. Long-term or overdose use may produce symptoms similar to those of hormone drugs.

The main ingredient of this product is medroxyprogesterone acetate

This product is a hard capsule, and the contents are white powder.

Used for palliative or adjuvant treatment of inoperable, recurrent or metastatic hormone-dependent tumors, such as endometrial cancer, renal cancer, breast cancer, etc.

This product must be taken under doctor's advice. Endometrial cancer and kidney cancer: 0.2-0.4g per day; breast cancer: 0.4-0.8g per day, or even up to 1g per day. Sex hormone therapy requires at least 8 to 10 weeks of treatment to respond. Palliative treatment of cachexia and pain in patients with various cancers: 0.5-1g/day. Bone marrow protection during chemotherapy for various cancers: 0.5-1g/day (from one week before chemotherapy to one week after a course of treatment).

Similar to other progesterone drugs, breast pain, galactorrhea, amenorrhea, cervical erosion or changes in cervical secretion, and gynecomastia may occur. Mental aspects: nervousness, insomnia, drowsiness, fatigue, dizziness. Skin and mucous membranes: Allergic reactions including itching, hives, angioedema to systemic rash and defenseless reactions have been reported. In a few cases, there are acne, baldness or hirsutism. Gastrointestinal: Nausea and indigestion, especially at higher doses. It may also produce similar adrenal cortisol reactions and hypercalcemia reactions, and occasionally obstructive jaundice has been reported.

Various thromboembolic diseases (thrombophlebitis, pulmonary embolism, etc.), severe liver damage, hypercalcemia due to bone metastasis, menorrhagia, pregnant or lactating women, and those who are allergic to medroxyprogesterone acetate.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not allowed. Precautions for the elderly: Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your pharmacist or doctor for details.

Keep away from light, sealed and stored in a dry place.

0.1 g

36 months

Nanjing Cuccess Pharmaceutical Co., Ltd.

• Founded in:

  2002-03-20

• Address:

  No. 20, Xingang Avenue, Nanjing Economic and Technological Development Zone

• Tax NO.:

  913201926089285606

• Registered Funds:

  60 million yuan

• Website:

  Log in to view

• Email:

  Log in to view